Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBSC and Hyaluronic Acid for Articular Cartilage Regeneration
NCT01076673Phase 2Completed
- Sponsor
- Kuala Lumpur Sports Medicine Centre
- Start
- Oct 2009
- Primary completion
- May 2012
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of peripheral blood stem cells in articular cartilage disorder of the knee, sponsored by Kuala Lumpur Sports Medicine Centre. Primary endpoint: Tissue Histology and MRI Evaluation at 18 months. Started Oct 2009; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
articular cartilage disorder of the knee
Beyond the preview
Go deeper on NCT01076673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01076673.